$BTCY News

Biotricity, Inc to Present at the LD Micro Invitational XVI

Biotricity Q3 2026 Earnings Call: Complete Transcript

Biotricity Inc (BTCY) Q3 2026 Earnings Call Highlights: Strong Revenue Growth and Strategic AI ...

Biotricity Delivers Strong Q3 Fiscal 2026 Performance, Growing Revenue Momentum and Expanding EBITDA

Biotricity Q3 EPS $(0.04) Beats $(0.08) Estimate, Sales $3.988M Miss $4.100M Estimate

Biotricity, Inc. (BTCY) Q3 2026 Earnings Call Transcript

Earnings Preview: Biotricity

Biotricity to Announce Continued Growth in Fiscal 2026 Third Quarter Financial Results and Business Update Call on February 11th

Biotricity Inc (BTCY) Q2 2026 Earnings Call Highlights: Revenue Surge and Strategic Expansion

Biotricity Strengthens Path to Scalable Profitability with Sustained Margins & Operational Efficiency in Second Quarter Fiscal 2026

Biotricity, Inc. (BTCY) Q2 2026 Earnings Call Transcript

Fate Therapeutics (FATE) Reports Q3 Loss, Beats Revenue Estimates

Pulmonx Corporation (LUNG) Reports Q3 Loss, Beats Revenue Estimates

Biotricity to Host Fiscal 2026 Second Quarter Financial Results and Business Update Call on November 14th

Fulgent Genetics, Inc. (FLGT) Surpasses Q3 Earnings and Revenue Estimates

Doximity (DOCS) Tops Q2 Earnings and Revenue Estimates

Health-E Commerce® and Biotricity® Collaborate to Expand Remote Cardiac Monitoring with Bioheart® for Flexible Spending Account (FSA) and Health Savings Account (HSA) Users

Biotricity and B-Secur Target the Consumer Wearables Market with Expansion of Next-Gen Cardiac Monitoring Platform

Are Medical Stocks Lagging Biotricity (BTCY) This Year?

Biotricity Q1 EPS $(0.03) Up From $(0.07) YoY, Sales $3.874M Beat $3.800M Estimate